The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. (Q34589360)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

multiple sclerosis

0 references

0 references

0 references

cannabinoid receptor

0 references

Javier Palazuelos

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Raphael Mechoulam

6

object named as

Raphael Mechoulam

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Nathalie Davoust

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Boris Julien

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Eric Hatterer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Tania Aguado

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Cristina Benito

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Augusto Silva

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Manuel Guzmán

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Serge Nataf

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Ismael Galve-Roperh

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

0 references

publication date

11 March 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Journal of Biological Chemistry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

283

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

13320-13329

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334483%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

The molecular logic of endocannabinoid signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Emerging properties of cannabinoid medicines in management of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoids control spasticity and tremor in a multiple sclerosis model

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoids and neuroinflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid-based drugs as anti-inflammatory therapeutics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid receptors as therapeutic targets.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M707960200

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34589360&oldid=1740037259"